Strategic partnership Leverage Illumina Ventures’ close relationship with Illumina to position co-investment or collaboration opportunities that align genomics tooling, diagnostics, and precision medicine with portfolio needs.

Early-stage focus Target incubators and seed-stage genomics startups in need of strategic guidance, capital, and access to a broad ecosystem; offer pilot projects or proof-of-concept collaborations to accelerate market-ready solutions.

Genomics workflow Offer tools and services that complement Illumina Ventures’ portfolio in life science tools, clinical diagnostics, and therapeutics, emphasizing data infrastructure, cloud enablement, and AI-assisted discovery.

Geographic collaboration Capitalize on their collaboration with Ireland-based genomics initiatives and international networks to source deals and establish regional pilots, partnerships, or co-development programs.

Portfolio expansion Propose value-add offerings such as technical due diligence, market validation, and fundraising support to expand the firm’s portfolio in high-growth areas like liquid biopsy, cfDNA analysis, and AI-driven biotech.